These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24467192)

  • 21. Post-translational regulation of gene expression using the ATF4 oxygen-dependent degradation domain for hypoxia-specific gene therapy.
    Cho SH; Oh B; Kim HA; Park JH; Lee M
    J Drug Target; 2013 Nov; 21(9):830-6. PubMed ID: 23952904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
    Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
    Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain.
    Kim HA; Kim K; Kim SW; Lee M
    J Control Release; 2007 Aug; 121(3):218-24. PubMed ID: 17628167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
    Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
    Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
    Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C
    Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
    Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
    Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
    Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Inflammatory Therapeutic Effect of Adiponectin Gene Delivery Using a Polymeric Carrier in an Acute Lung Injury Model.
    Piao C; Park JH; Lee M
    Pharm Res; 2017 Jul; 34(7):1517-1526. PubMed ID: 28493099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
    Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
    J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma.
    Li X; Xie Z; Xie C; Lu W; Gao C; Ren H; Ying M; Wei X; Gao J; Su B; Ren Y; Liu M
    Bioconjug Chem; 2015 Aug; 26(8):1494-503. PubMed ID: 26052814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma.
    Lee SJ; Kim SJ; Seo HH; Shin SP; Kim D; Park CS; Kim KT; Kim YH; Jeong JS; Kim IH
    Cancer Lett; 2012 Jul; 320(1):72-80. PubMed ID: 22269208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.
    Kim HA; Lim S; Moon HH; Kim SW; Hwang KC; Lee M; Kim SH; Choi D
    Pharm Res; 2010 Oct; 27(10):2075-84. PubMed ID: 20607367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system.
    Lee M; Lee ES; Kim YS; Choi BH; Park SR; Park HS; Park HC; Kim SW; Ha Y
    Spine (Phila Pa 1976); 2005 Dec; 30(24):2729-34. PubMed ID: 16371895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.
    Kia A; Przystal JM; Nianiaris N; Mazarakis ND; Mintz PJ; Hajitou A
    Mol Cancer Ther; 2012 Dec; 11(12):2566-77. PubMed ID: 23053496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system.
    Liu ML; Oh JS; An SS; Pennant WA; Kim HJ; Gwak SJ; Yoon DH; Kim KN; Lee M; Ha Y
    J Gene Med; 2010 Dec; 12(12):990-1001. PubMed ID: 21157823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex.
    Wang J; Lei Y; Xie C; Lu W; Yan Z; Gao J; Xie Z; Zhang X; Liu M
    Int J Pharm; 2013 Dec; 458(1):48-56. PubMed ID: 24144951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
    Schoensiegel F; Paschen A; Sieger S; Eskerski H; Mier W; Rothfels H; Kleinschmidt J; Schadendorf D; Haberkorn U
    Cancer Gene Ther; 2004 Jun; 11(6):408-18. PubMed ID: 15118759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma.
    Yu BF; Wu J; Zhang Y; Sung HW; Xie J; Li RK
    Cancer Gene Ther; 2013 May; 20(5):290-7. PubMed ID: 23598435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy.
    Fu C; Lin L; Shi H; Zheng D; Wang W; Gao S; Zhao Y; Tian H; Zhu X; Chen X
    Biomaterials; 2012 Jun; 33(18):4589-96. PubMed ID: 22445251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.